United Kingdom
# |
Name |
Return on Assets (ROA) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
60.21%
|
March 31, 2024 | USD 11.13 | -2.11% |
|
United Kingdom |
|
2 |
48.65%
|
Aug. 31, 2023 | USD 0.11 | -15.01% |
|
United Kingdom |
|
3 |
19.36%
|
Dec. 31, 2023 | USD 0.23 | -1.64% |
|
United Kingdom |
|
4 |
0.85%
|
March 31, 2024 | USD 0.79 | 0.22% |
|
United Kingdom |
|
5 |
0.77%
|
June 30, 2024 | USD 22.63 | -1.63% |
|
United Kingdom |
|
6 |
-9.26%
|
Dec. 31, 2023 | USD 32.88 | 0.83% |
|
United Kingdom |
|
7 |
-13.69%
|
Dec. 31, 2023 | USD 1.16 | -5.69% |
|
United Kingdom |
|
8 |
-30.35%
|
Dec. 31, 2023 | USD 13.39 | 4.86% |
|
United Kingdom |
|
9 |
-41.94%
|
Dec. 31, 2023 | USD 16.92 | 0.06% |
|
United Kingdom |
|
10 |
-44.31%
|
Dec. 31, 2023 | USD 3.01 | 2.73% |
|
United Kingdom |
|
11 |
-46.12%
|
Dec. 31, 2023 | USD 5.33 | 1.52% |
|
United Kingdom |
|
12 |
-55.51%
|
Dec. 31, 2023 | USD 2.21 | 0.46% |
|
United Kingdom |
|
13 |
-55.63%
|
Dec. 31, 2023 | USD 0.68 | -3.32% |
|
United Kingdom |
|
14 |
-62.04%
|
June 30, 2024 | USD 0.07 | -11.35% |
|
United Kingdom |
|
15 |
-64.29%
|
Dec. 31, 2023 | USD 14.69 | 0.22% |
|
United Kingdom |
|
16 |
-122.79%
|
March 31, 2024 | USD 1.69 | 0.00% |
|
United Kingdom |
|
17 |
-167.61%
|
Dec. 31, 2023 | USD 0.05 | 0.22% |
|
United Kingdom |
The Vaccines company in United Kingdom with the highest Return on Assets (ROA) is Roivant Sciences Ltd. (NasdaqGS: ROIV) at 60.21%.
The Vaccines company in United Kingdom with the lowest Return on Assets (ROA) is GENinCode plc (LSE: GENI.L) at -167.61%.
The top 10 Vaccines companies in United Kingdom by Return on Assets (ROA) are Roivant Sciences Ltd., Oncimmune Holdings plc, hVIVO plc, ECO Animal Health Group plc, Genus plc, Immunocore Holdings plc, Aptorum Group Limited, Bicycle Therapeutics plc, Centessa Pharmaceuticals plc and Mereo BioPharma Group plc.
The bottom 10 Vaccines companies in United Kingdom by Return on Assets (ROA) are GENinCode plc, Virax Biolabs Group Limited, 4basebio PLC, Allergy Therapeutics plc, Arecor Therapeutics plc, Autolus Therapeutics plc, Silence Therapeutics plc, Mereo BioPharma Group plc, Centessa Pharmaceuticals plc and Bicycle Therapeutics plc.